Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
- Drug Discovery
- ribonucleic acid
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 369308
The Patent Application is entitled Uses of Thioredoxin.
The field of use for the invention is as an anticancer drug, as a screening tool to identify new cancer drugs, and/or as a mitogenic tissue culture reagent.
IPSCIO Record ID: 344542
The Patents are for Methods of Treatment with Drug Loaded Polymeric Materials.
IPSCIO Record ID: 383615
The Patent Rights are titled A Method and Apparatus for Holding Cells.
The Cancer Diagnostics Field shall mean diagnostic assays to detem1ine therapeutic efficacy of then-available chemotherapeutics or biologics on cancer or screening assays for the detection of cancer.
The Drug Development Field shall mean research conducted to measure the effect of preclinical, clinical or commercial stage cancer agents on primary or early passage cell strains.
IPSCIO Record ID: 263910
MicroRNAs have been shown to hold tremendous potential as a new class of prospective drug targets with significant therapeutic opportunity.
MicroRNAs (miRNAs) are a recently discovered, naturally occurring form of RNAi. These small RNAs act as protein regulators and have the potential to form the basis for a new class of diagnostics and therapeutics. Since many diseases are caused by the abnormal activity of proteins, the ability to selectively regulate protein activity through microRNAs could provide the means to treat a wide range of human diseases. In addition, microRNA expression levels have been shown to be correlated with various disease states and to hold great potential as diagnostics and prognostic markers
Licensee's lead therapeutic development program for liver cancer (hepatocellular carcinoma or HCC) has so far identified four microRNAs that when inhibited in vitro lead to a decrease in liver cancer cell proliferation.